Pediatrics - Pulmonology
Testing strategies for diagnosing tuberculosis in young children
24 Feb, 2021 | 02:05h | UTCSensitive and Feasible Specimen Collection and Testing Strategies for Diagnosing Tuberculosis in Young Children – JAMA Pediatrics (free for a limited period)
Editorial: Diagnosing Childhood Tuberculosis: A Small Step Forward (free for a limited period)
Commentary: Diagnosing Pediatric TB in the Resource-Limited Areas – Physician’s Weekly
Schools may see a burst of the common cold when they reopen, research suggests
24 Feb, 2021 | 02:51h | UTCSchools may see a burst of the common cold when they reopen, research suggests – STAT
SR: Multisystem inflammatory syndrome in children related to COVID-19
21 Feb, 2021 | 22:11h | UTC
Commentary on Twitter (thread – click for more)
Very proud to present our systematic review on the hyperinflammatory syndrome associated with SARS-CoV-2 in children #PIMS_TS #MISC, as published today in @EurJPediatrics.
We analyzed and summarized over 950 cases from more than 60 records. https://t.co/jO3te1KUIE
(1/n) pic.twitter.com/6BwEw7qFzi
— Levi Hoste (@LeviHoste) February 18, 2021
Cohort study: Factors associated with severe SARS-CoV-2 infection in children
17 Feb, 2021 | 01:38h | UTCFactors Associated With Severe SARS-CoV-2 Infection – Pediatrics
Commentary: Large study outlines risk factors for severe COVID-19 in children – 2 Minute Medicine
RCT: Delayed antibiotic prescription feasible for children with uncomplicated respiratory infections
12 Feb, 2021 | 02:02h | UTCDelayed Antibiotic Prescription for Children With Respiratory Infections: A Randomized Trial – Pediatrics (link to abstract – $ for full-text)
Commentary: Data support delayed antibiotics in kids with respiratory infections – CIDRAP
Study: New B.1.1.7 variant does not result in more severe disease in children compared to the original strain
12 Feb, 2021 | 02:23h | UTC
Commentary on Twitter
There were recent concerns and media reports that B.1.1.7 has more effects in children and young adults than the ancestral strain. Here are new data to provide reassurance that's not the case @LancetChildAdol https://t.co/85Dj4tl2qq pic.twitter.com/YmNOeOhpTB
— Eric Topol (@EricTopol) February 11, 2021
ERS guidelines for the management of children and adolescents with bronchiectasis
11 Feb, 2021 | 02:05h | UTC
RCT: Posaconazole noninferior to voriconazole for primary treatment of invasive aspergillosis
7 Feb, 2021 | 21:00h | UTCPosaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial – The Lancet (link to abstract – $ for full-text)